Rare diseases
Investigational molecules
Locations
Study on Eltrekibart and Mirikizumab for Adults with Moderate to Severe Ulcerative Colitis
BelgiumStudy of mirikizumab versus azathioprine in newly diagnosed moderate-to-severe Crohn’s disease patients
GermanyStudy of ly4395089 and mirikizumab in adults with moderately to severely active Crohn’s disease
BelgiumA study of mirikizumab levels in breast milk of breastfeeding women with ulcerative colitis or Crohn's disease
DenmarkA study of LY4268989 and mirikizumab in adults with moderately to severely active ulcerative colitis
AustriaA study testing how well mirikizumab works to achieve transmural healing in patients with Crohn's Disease
FranceComparing mirikizumab versus azathioprine with glucocorticoids in newly diagnosed patients with moderate-to-severe ulcerative colitis
GermanyStudy of Mirikizumab for Children with Moderate to Severe Crohn's Disease
AustriaStudy on Preventing Crohn's Disease Recurrence After Surgery Using Risankizumab and Drug Combination in Adults at Risk
BelgiumStudy on Bowel Urgency in Adults with Moderate to Severe Ulcerative Colitis Treated with Mirikizumab
AustriaStudy on Mirikizumab for Children and Teens with Moderate to Severe Ulcerative Colitis
BelgiumTell us about your condition – we search every trial in Europe and connect you with the right site.
